Stock Market Today

19 March 2026

Singapore stocks gained 1.3 per cent on Wednesday (Mar 18). UOL led the gainers, rising 4.9 per cent or S$0.48 to end at S$10.20. The worst performer was Singtel, which fell 0.8 per cent or S$0.04 to close at S$5.13.

Wall Street ended sharply lower on Wednesday (Mar 18). The S&P 500 declined 1.36 per cent to end the session at 6,624.70 points. The Nasdaq declined 1.46 per cent to 22,152.42 points, while the Dow Jones Industrial Average declined 1.63 per cent to 46,225.15 points.

Singapore Technical Highlights

Factsheets


TOP 5 GAINERS & LOSERS

Factsheets


Events Of The Week

Factsheets


SG

Manulife US REIT’s portfolio valuation falls 1.6% as at end-2025; FY2025 revenue drops 32% y-o-y to US$113.9 million.

Construction on the second phase of Jurong Island Logistics Hub (JILH) has continued into March 2026, with structural works for the third and fourth floors under way, said Cosco Shipping International (Singapore).

Reclaims Global to acquire freehold B1 industrial property at Tagore Industrial Avenue for S$20.5 million.

Wing Tai’s Malaysian subsidiary obtains freehold land parcel at Mont Kiara for RM45 million.

Hotel Properties Ltd (HPL) has priced S$150 million in perpetual securities at 4.38 per cent.


US

Federal Reserve holds interest rates steady, keeps 1 cut in play this year as uncertainty mounts.

Micron revenue almost triples, tops estimates as demand for memory soars.

Vice President JD Vance and Energy Secretary Chris Wright will meet Thursday with the oil industry as the White House looks for ways to address surging fuel prices.

Samsung Electronics Co agreed to supply and collaborate with Advanced Micro Devices Inc (AMD) on next-generation artificial intelligence (AI) memory and computing technologies.

Meta is shutting down VR social platform Horizon Worlds in further pivot away from the metaverse.

Macy’s store revamp shows progress, but company expects sales to fall this year.

Johnson & Johnson on Wednesday said the US Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots.

Source: SGX Masnet, Bloomberg, Channel NewsAsia, Reuters, CNBC, WSJ, The Business Times, The Edge Singapore, PSR


RESEARCH REPORTS

Magnificent 7 Monthly: Feb 26 – February pullback from AI ROI scepticism

Analyst: Phillip Research Team

  • Mag-7 stocks fell by 6.7% in Feb26 (Jan26: +0.2%), underperforming both the S&P 500 (-1.4%) and NASDAQ (-3.8%). The decline came from a broader market reassessment of aggressive AI capital expenditures versus near-term ROI.
  • Majority of the MAG7 pulled back in Feb26 as MSFT (-18.4%) was weighed down by growing market scepticism regarding the profitability and payoff timeline of its heavy AI infrastructure build-out, and AMZN (-13.8%) was sold following its announcement to sacrifice short-term margins for a US$200bn long-term AI hardware bet. TSLA (+5.4%) was the biggest gainer from a recovery in China and European vehicle sales.
  • We maintain OVERWEIGHT on the Mag-7. The Feb26 pullback, triggered by the Iran conflict and renewed inflation fears, presents an attractive entry point. While energy shocks cement a higher-for-longer rate environment, the Mag-7 remain insulated. Their net cash balance sheets and robust free cash flow effectively neutralise elevated borrowing costs. Secular AI adoption and sovereign tech investments outweigh duration risk. Excluding TSLA, Mag-7 earnings will continue to outpace the S&P 500 and Nasdaq 100, anchored by non-cyclical demand and the US AI Action Plan.



Market Journal articles powered by PhillipGPT

SIA Engineering Posts Strong Q3 Results on Associate Earnings Growth

Raffles Medical Group Faces Sluggish Growth on Mixed Results

Grab Holdings Achieves First Full Year of Net Profit with Strong Revenue Growth


PSR Stocks Coverage

Factsheets


For more information, please visit:

https://www.stocksbnb.com/singapore-stocks-coverage/


Upcoming Webinars

Corporate Insights by LHN Ltd

Date & Time: 25 March 26 | 12PM-1PM

Register: poems-20260325-140477


Corporate Insights by Lum Chang Creations Limited

Date & Time: 27 March 26 | 12PM-1PM

Register: poems-20260327-141688


Corporate Insights by Thakral Corporation Ltd

Date & Time: 31 March 26 | 12PM-1PM

Register: poems-20260331-141690


Corporate Insights by Thakral Corporation Ltd

Date & Time: 31 March 26 | 6PM-9PM

Register: poems-20260331-141692


Corporate Insights by Beng Kuang Marine [NEW]

Date & Time: 2 April 26 | 12PM-1PM

Register: poems-20260402-142364


Strategy & Stock Picks (Investment Symposium 2026) – SG Market [NEW]

Date & Time: 11 April 26 | 2.30PM-6PM

Register: poems-20260411-142749


POEMS Podcast:

Research Videos

https://www.youtube.com/embed/v72GfRG-rG8?list=PLv41YzcbRaXG98t4efd7aXkAfH33gq-2u
Date: 16 March 2026

Click here for more on Market Outlook.
Sign up for our webinars here, and be among the first to receive economy and market updates.

PHILLIP RESEARCH IN 3 MINS

Follow our Socials

Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon Linkedin Social Icon TikTok Social Icon Spotify Social Icon

Join our Singapore Equity Research Community on POEMS Mobile 3 App for the latest research reports, market updates, insights and more

Click to join!

Disclaimer

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com